Literature DB >> 19908922

Swimming upstream: comparative effectiveness research in the US.

Jeremy A Greene1.   

Abstract

Mesh：

Year:  2009        PMID： 19908922     DOI： 10.2165/11319910-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  13 in total

1.  Claims of equivalence in medical research: are they supported by the evidence?

Authors:  W L Greene; J Concato; A R Feinstein
Journal:  Ann Intern Med       Date:  2000-05-02       Impact factor: 25.391

2.  Prednisolone ointment and hydrocortisone ointment; comparative effectiveness in dermatological therapy.

Authors:  C C SMITH
Journal:  AMA Arch Derm       Date:  1956-10

3.  Quality of reporting of noninferiority and equivalence randomized trials.

Authors:  Anne Le Henanff; Bruno Giraudeau; Gabriel Baron; Philippe Ravaud
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

4.  Debate about funding comparative-effectiveness research.

Authors:  Jerry Avorn
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

Review 5.  Methodological standards for assessing therapeutic equivalence.

Authors:  B Kirshner
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

6.  Comparative effectiveness research and evidence-based health policy: experience from four countries.

Authors:  Kalipso Chalkidou; Sean Tunis; Ruth Lopert; Lise Rochaix; Peter T Sawicki; Mona Nasser; Bertrand Xerri
Journal:  Milbank Q       Date:  2009-06       Impact factor: 4.911

7.  The continuing unethical use of placebo controls.

Authors:  K J Rothman; K B Michels
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

8.  The neglected purpose of comparative-effectiveness research.

Authors:  Aanand D Naik; Laura A Petersen
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

Review 9.  The policy debate over public investment in comparative effectiveness research.

Authors:  Eugene C Rich
Journal:  J Gen Intern Med       Date:  2009-04-21       Impact factor: 5.128

10.  Equivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-08-17
View more
  2 in total

1.  Perspectives on comparative effectiveness research: views from diverse constituencies.

Authors:  Dave Nellesen; Howard G Birnbaum; Paul E Greenberg
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Prioritizing comparative effectiveness research: are drug and implementation trials equally worth funding?

Authors:  Afschin Gandjour
Journal:  Pharmacoeconomics       Date:  2011-07       Impact factor: 4.558
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.